Source:http://linkedlifedata.com/resource/pubmed/id/12725000
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
674
|
pubmed:dateCreated |
2003-5-2
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
N
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0038-0814
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
53-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12725000-Anti-Bacterial Agents,
pubmed-meshheading:12725000-Bacterial Infections,
pubmed-meshheading:12725000-Benchmarking,
pubmed-meshheading:12725000-Humans,
pubmed-meshheading:12725000-Patient Selection,
pubmed-meshheading:12725000-Risk Factors,
pubmed-meshheading:12725000-Urinary Tract Infections
|
pubmed:year |
2003
|
pubmed:articleTitle |
[Best practice drug therapy. B. Use of antibiotics 8/urinary infections].
|
pubmed:affiliation |
CHU de Besançon.
|
pubmed:publicationType |
Journal Article
|